Cargando…

Allosteric modulators enhance agonist efficacy by increasing the residence time of a GPCR in the active state

Much hope in drug development comes from the discovery of positive allosteric modulators (PAM) that display target subtype selectivity and act by increasing agonist potency and efficacy. How such compounds can allosterically influence agonist action remains unclear. Metabotropic glutamate receptors...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Anne-Marinette, Quast, Robert B., Fatemi, Fataneh, Rondard, Philippe, Pin, Jean-Philippe, Margeat, Emmanuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440590/
https://www.ncbi.nlm.nih.gov/pubmed/34521824
http://dx.doi.org/10.1038/s41467-021-25620-5
_version_ 1783752708375707648
author Cao, Anne-Marinette
Quast, Robert B.
Fatemi, Fataneh
Rondard, Philippe
Pin, Jean-Philippe
Margeat, Emmanuel
author_facet Cao, Anne-Marinette
Quast, Robert B.
Fatemi, Fataneh
Rondard, Philippe
Pin, Jean-Philippe
Margeat, Emmanuel
author_sort Cao, Anne-Marinette
collection PubMed
description Much hope in drug development comes from the discovery of positive allosteric modulators (PAM) that display target subtype selectivity and act by increasing agonist potency and efficacy. How such compounds can allosterically influence agonist action remains unclear. Metabotropic glutamate receptors (mGlu) are G protein-coupled receptors that represent promising targets for brain diseases, and for which PAMs acting in the transmembrane domain have been developed. Here, we explore the effect of a PAM on the structural dynamics of mGlu2 in optimized detergent micelles using single molecule FRET at submillisecond timescales. We show that glutamate only partially stabilizes the extracellular domains in the active state. Full activation is only observed in the presence of a PAM or the G(i) protein. Our results provide important insights on the role of allosteric modulators in mGlu activation, by stabilizing the active state of a receptor that is otherwise rapidly oscillating between active and inactive states.
format Online
Article
Text
id pubmed-8440590
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-84405902021-10-04 Allosteric modulators enhance agonist efficacy by increasing the residence time of a GPCR in the active state Cao, Anne-Marinette Quast, Robert B. Fatemi, Fataneh Rondard, Philippe Pin, Jean-Philippe Margeat, Emmanuel Nat Commun Article Much hope in drug development comes from the discovery of positive allosteric modulators (PAM) that display target subtype selectivity and act by increasing agonist potency and efficacy. How such compounds can allosterically influence agonist action remains unclear. Metabotropic glutamate receptors (mGlu) are G protein-coupled receptors that represent promising targets for brain diseases, and for which PAMs acting in the transmembrane domain have been developed. Here, we explore the effect of a PAM on the structural dynamics of mGlu2 in optimized detergent micelles using single molecule FRET at submillisecond timescales. We show that glutamate only partially stabilizes the extracellular domains in the active state. Full activation is only observed in the presence of a PAM or the G(i) protein. Our results provide important insights on the role of allosteric modulators in mGlu activation, by stabilizing the active state of a receptor that is otherwise rapidly oscillating between active and inactive states. Nature Publishing Group UK 2021-09-14 /pmc/articles/PMC8440590/ /pubmed/34521824 http://dx.doi.org/10.1038/s41467-021-25620-5 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Cao, Anne-Marinette
Quast, Robert B.
Fatemi, Fataneh
Rondard, Philippe
Pin, Jean-Philippe
Margeat, Emmanuel
Allosteric modulators enhance agonist efficacy by increasing the residence time of a GPCR in the active state
title Allosteric modulators enhance agonist efficacy by increasing the residence time of a GPCR in the active state
title_full Allosteric modulators enhance agonist efficacy by increasing the residence time of a GPCR in the active state
title_fullStr Allosteric modulators enhance agonist efficacy by increasing the residence time of a GPCR in the active state
title_full_unstemmed Allosteric modulators enhance agonist efficacy by increasing the residence time of a GPCR in the active state
title_short Allosteric modulators enhance agonist efficacy by increasing the residence time of a GPCR in the active state
title_sort allosteric modulators enhance agonist efficacy by increasing the residence time of a gpcr in the active state
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440590/
https://www.ncbi.nlm.nih.gov/pubmed/34521824
http://dx.doi.org/10.1038/s41467-021-25620-5
work_keys_str_mv AT caoannemarinette allostericmodulatorsenhanceagonistefficacybyincreasingtheresidencetimeofagpcrintheactivestate
AT quastrobertb allostericmodulatorsenhanceagonistefficacybyincreasingtheresidencetimeofagpcrintheactivestate
AT fatemifataneh allostericmodulatorsenhanceagonistefficacybyincreasingtheresidencetimeofagpcrintheactivestate
AT rondardphilippe allostericmodulatorsenhanceagonistefficacybyincreasingtheresidencetimeofagpcrintheactivestate
AT pinjeanphilippe allostericmodulatorsenhanceagonistefficacybyincreasingtheresidencetimeofagpcrintheactivestate
AT margeatemmanuel allostericmodulatorsenhanceagonistefficacybyincreasingtheresidencetimeofagpcrintheactivestate